Review Articles
Vol. 7 (2015): Review Series, Original Articles, Case Reports

NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: August 4, 2015
Accepted: August 24, 2015
Published: August 30, 2015
3478
Views
1134
Downloads
1772
HTML
Hematology

Authors

Nasal, natural-killer T-cell lymphoma (nasal NKTCL ), is a rare presentation of extranodal lymphoma in North-America and Europe, but in some countries, as China and Korea, it is extremely common: 20 to 46 % of  T-cell lymphomas. Some studies, analyzed the incidence in Latin-America, but Mexico,  based on political and geographic  considerations, was not  included in these reports. Thus, we performed a retrospective analysis of the patients diagnosed and treated  as nasal, NKTCL, in our institution, that is an academic tertiary national reference hospital. From 1988 to 2014, we diagnosed and treated  14,816 cases of non-Hodgkin’s  lymphoma,  10,957 (73%) were of B-cell  histology and 3822 (26%) were of T-cell histology. Nasal, NKTCL, was the most frequent  of  the T-cell histology: 40%. We compare our results with  other countries and  observed that  nasal, NKTCL  has a low  number of cases in North-America, and some countries in Latin-America, as Argentina, Brazil  and Chile,  but our  number will be similar to Guatemala and Peru, that were  similar to China and Korea.  We think that this neoplasm has a racial basis, independent  of environmental factors.

Downloads

Download data is not yet available.

Citations

Ethics Approval

Review Article

How to Cite



“NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION” (2015) Mediterranean Journal of Hematology and Infectious Diseases, 7(1), p. e2015052. doi:10.4084/mjhid.2015.052.